Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia

Go back to Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Pfizer Inc. (NYSE: PFE) Delayed: 43.89 -0.58 (1.3%)
Previous Close $44.47    52 Week High $37.39 
Open $44.17    52 Week Low $28.25 
Day High $44.46    P/E 26.60 
Day Low $43.31    EPS $1.65 
Volume 56,416,761